"Will I need radiotherapy?" is one of the first questions patients ask after a colorectal cancer diagnosis. The honest answer is: it depends almost entirely on exactly where the cancer is located — and the distinction matters more than most patients expect.
"Colorectal cancer" is really an umbrella term covering two related but anatomically distinct cancers — colon cancer and rectal cancer. Despite both arising from the large bowel and sharing many risk factors, they are treated quite differently when it comes to radiation therapy.
The simplest way to think about it: most colon cancers do not require radiation. Many rectal cancers do.
The rectum sits low in the pelvis, surrounded by a confined bony space and in close proximity to other pelvic organs, nerves, and blood vessels. This makes achieving a wide surgical margin technically harder than in the colon, which has more room to work with in the abdominal cavity. Radiation helps shrink rectal tumours before surgery, making complete removal more achievable and reducing the chance the cancer returns locally in that tight pelvic space — a risk that is much lower for colon cancer to begin with.
Not every rectal cancer needs radiation either. The decision depends on the stage and specific features of the tumour, usually determined through MRI staging and sometimes endoscopic ultrasound before treatment begins.
Tumours that have grown through the rectal wall or involve nearby lymph nodes (Stage II–III) are the group most likely to benefit from radiation before surgery — this is the most common scenario where radiation is recommended.
Low rectal tumours near the sphincter muscles benefit from pre-operative shrinkage, sometimes making the difference between needing a permanent stoma and being able to preserve normal bowel function.
When imaging shows the tumour is very close to the edge of the planned surgical resection, radiation beforehand helps create a safer distance from critical surrounding structures.
Cancer that has returned after previous treatment in the pelvis often requires radiation as part of a fresh treatment plan, particularly if the area wasn't previously irradiated.
For rectal cancer, radiation is most commonly given before surgery (neoadjuvant), though there are situations where it's used afterward instead.
Combined with chemotherapy over several weeks, this approach shrinks the tumour, makes it easier to achieve clear margins, and reduces the risk of local recurrence. Surgery typically follows 6–8 weeks later, allowing the tissue to respond fully.
An alternative approach using a more concentrated radiation schedule over about a week, followed by surgery within days — used in certain clinical situations based on tumour characteristics and patient factors.
Less common today, but may be used if pathology after surgery reveals features suggesting a higher risk of local recurrence than was apparent before the operation.
When radiation is part of the plan, it changes the sequence and timing of treatment — but doesn't change the eventual need for surgery in most cases. Surgery remains the definitive treatment for both colon and rectal cancer; radiation is a tool used specifically to improve the chances of a complete, durable surgical result in rectal cancer's more anatomically challenging location.
This is why accurate staging — through MRI of the pelvis and sometimes endoscopic ultrasound — is so important before any treatment begins. Getting the sequence right from the start (radiation first, or straight to surgery) has a real impact on both cancer control and quality of life afterward, including bowel function and the likelihood of needing a stoma.
The key takeaway: If you've been diagnosed with colorectal cancer, ask your surgeon specifically whether your cancer is in the colon or the rectum, and what stage it is — these two pieces of information determine almost everything about whether radiation will be part of your treatment plan.
Book a consultation with Dr Cha to discuss your diagnosis and treatment options.
Book an Appointment